Increasing the cutoff value for ferritin levels may substantially increase the number of individuals diagnosed with iron deficiency anemia.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/new-ferritin-threshold-affects-diagnosis-rates-anemia-2025a1000mh0
via IFTTT

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/public/bios/ed-womenshealth#Bernstein
via IFTTT

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/public/bios/ed-womenshealth#Johnson
via IFTTT

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/public/bios/ed-womenshealth#Lewiecki
via IFTTT

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/public/bios/ed-womenshealth#Manson
via IFTTT

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/public/bios/ed-womenshealth#Wysocki
via IFTTT

Check drug interactions, access 450+ medical calculators, and ID pills at the point-of-care with Medscape’s official app. No hidden costs or subscription fees.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/public/medscapeapp?src=ban_strip_mscpmrk_app
via IFTTT

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/public/bios/ed-womenshealth#Bradley
via IFTTT

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/public/bios/ed-womenshealth#Kovacs
via IFTTT

The MHRA has approved zuranolone, the UK’s first oral treatment for postnatal depression, offering a faster-acting alternative to existing therapies.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/uk-authorises-first-pill-postnatal-depression-2025a1000mwu
via IFTTT